Not exact matches
In addition, the development of therapies that could potentially halt patients» progression from pancreatic inflammation to diabetes has been hampered by the long lead times needed in order to tell whether a given therapy has an effec
In addition, the
development of therapies that could potentially halt
patients» progression from pancreatic inflammation to diabetes has been hampered by the long lead times needed
in order to tell whether a given therapy has an effec
in order to tell whether a
given therapy has an effect.
In a different study Waghmare presented at the recent annual meeting of the American Society for Blood and Marrow Transplantation in Orlando, Florida, the researchers teased out a few risk factors that can drive the development of lower respiratory tract infections — namely, high levels of steroid use (commonly given to transplant patients for other complications such as graft - v
In a different study Waghmare presented at the recent annual meeting of the American Society for Blood and Marrow Transplantation
in Orlando, Florida, the researchers teased out a few risk factors that can drive the development of lower respiratory tract infections — namely, high levels of steroid use (commonly given to transplant patients for other complications such as graft - v
in Orlando, Florida, the researchers teased out a few risk factors that can drive the
development of lower respiratory tract infections — namely, high levels of steroid use (commonly
given to transplant
patients for other complications such as graft - vs.
Given that infections are highly prevalent
in spinal cord injured
patients, orthodox antibiotic treatments start to lose their effectiveness with time due to the
development of resistances.
Given the slow growth of prostate cancer
development, this investigation offers novel and important information to physicians,
patients and the general public,» said lead author Jacques Baillargeon, UTMB professor of epidemiology
in the department of preventative medicine and community health.
A new study led by scientists at The Scripps Research Institute (TSRI) is
giving researchers a first look at the early stages of brain
development in patients with Fragile X syndrome, a disorder that causes mild to severe intellectual disability and is the most common genetic cause of autism spectrum disorder.
It is worthwhile to
give patients expensive new drugs that can cure their hepatitis C much earlier than some insurers are now willing to pay for them, according to a UC San Francisco study that models the effects of treating the disease early versus late
in its
development.
Identification of
patients sharing variants
in a
given gene and having phenotypic features
in common leads to greater certainty
in the pathogenic nature of the gene and enables to the role of novel genes
in development and disease to be defined.
«Instead of treating
patients after these abnormal blood vessels form
in the eye, we may be able to
give patients eye drops or systemic medications that prevent their
development in the first place.»
One review of studies published
in Current Neuropharmacology showed that Alzheimer's
patients that were
given melatonin experienced improved sleep patterns, reduced «sundowning» and delayed the
development of cognitive impairment.
• Take part
in patient conferences to
give feedback to care teams on
patient development.
Broadening our approach to understanding adaptive coping and management of emotional challenges may be of particular relevance to the
development of psychological support for this
patient group because of the uncertain outcome (i.e. whether resolution will ever be achieved through parenthood) and
given the evidence that some couples manage to find positive outcomes
in a traditionally negative infertility experience.